Mar 4, 2026
Medications Requiring Refrigeration: Proper Home Storage Guide
Explore how the FDA reviews biosimilars under the new 2025 guidance. Learn about the shift from clinical trials to analytical characterization, interchangeability rules, and what this means for patient access and drug costs.
The FDA doesn't rate biosimilars like generics-it evaluates them through a rigorous scientific process to prove they're highly similar and safe. Learn how biosimilars are approved, why they're different from generics, and what the Purple Book means for patients.